ICAM1 and breast carcinoma: Indeed, we found that some ICAM-1+ CTCs were associated with neutrophils in breast cancer patients (Figure 1C), suggesting that ICAM-1 on tumor cells may directly mediate tumor cells binding with neutrophils.